The Jetrail® project team is delighted to receive the award from the state of Carinthia.
Innovation and Research Award 2024 for on point medicals
On May 15, 2024, on point medicals GmbH was named this year’s winner of the Innovation and Research Award of the State of Carinthia (IFP) for its Jetrail® project at the Congress Center Villach. “With their innovative spirit, the award winners show very impressively what is possible from Carinthia and thus virtually anticipate the future. They are shining examples for many other innovative minds,” emphasized Governor Peter Kaiser. The IFP is the highest award that the KWF has presented annually on behalf of the state of Carinthia for excellent performance in the field of research and development since 2004
“The award winners
are shining examples for
many other innovative minds. “
„
With the “Jetrail® | Customized and safe aliquoting of blood serum” project, Onpoint won in the small and medium-sized enterprises category. This is a newly developed system for the fast, simple and sterile filling of blood serum for use as eye drops. With this innovation, Onpoint was also recommended for the “State Prize for Innovation” and the special “Econovius” award.
You can find the video and the company portrait of the innovation at https://kwf.at/on-point-jetrail/
Interesting posts
On point medicals has won the 2024 Innovations- and Research Award of the Federal State of Carinthia.
Dry eye disease (DED) is a prevalent and often underestimated ocular condition that affects millions of people worldwide. Find out more about causes, symptoms and treatment options.
Serum Eye Drops (SED) are similar to normal tears and show a high efficacy in therapy with patients suffering from severe ocular surface problems, such as Dry Eye Disease. Learn more about this widely unknown blood-derived therapy.
Blood irradiation is vital for patients at risk of developing TA-GvHD. Find out more about how to correctly verify blood irradiation and why dosimetry checks and the use of irradiation indicators should not be ignored or confused.
Blood irradiation is vital for patients at risk of developing TA-GvHD. Find out more about how to correctly verify blood irradiation and why dosimetry checks and the use of irradiation indicators should not be ignored or confused.
Cold chain management can ensure that unused blood products are returned to the blood bank safely. In times of blood shortages it is more than important that surplus blood products can be reused. More on why temperature monitoring is essential.
![[:de]Blutbesstrahlung vor einer Transfusion verhindert TA-GvHD[:en]Blood irradiation prior to transfusion prevents TA-GvHD[:]](https://onpointmedicals.at/wp-content/uploads/2021/11/What-is-blood-irradiation-scaled.jpg)
Blood is irradiated before transfusion in order to avoid the formation of the rare but mostly fatal TA-GvHD. Here is why it is much better to prevent this disease with blood irradiation than to diagnose it.
The transfusion-associated graft-versus-host reaction is a complication of blood transfusion in immunodeficient patients. Read here why it can arise and what serious reactions it causes.
The digital traceability of blood transfusions is of crucial importance - also if blood irradiation is involved. Find the latest developments in digital verification of blood irradiation in this article.
The irradiation process of blood products can currently be carried out with gamma or X-ray irradiation. But what are the differences and the latest developments between the two radiation sources?
